State Officials Urging Rx Pseudoephedrine Face Strong Lobby
This article was originally published in The Tan Sheet
Executive Summary
Officials from Mississippi, Missouri, Oregon and South Carolina and the National Narcotics Officers Associations Coalition testifying before a House subcommittee call for moving all PSE products to prescription status.
You may also be interested in...
Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms
Consumer products group backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.
Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms
Consumer products group backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.
Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms
CHPA backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.